iBio, Inc.

NasdaqCM:IBIO Stock Report

Market Cap: US$80.5m

iBio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IBIO?
Owner TypeNumber of SharesOwnership Percentage
Private Companies246,0870.712%
Individual Insiders800,3612.32%
VC/PE Firms1,953,4675.66%
Hedge Funds6,485,20018.8%
Institutions9,055,20526.2%
General Public16,003,24146.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 249.8%.

Top Shareholders

Top 25 shareholders own 50.98% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.53%
Affinity Asset Advisors, LLC
2,257,200US$5.3m9.72%0.35%
6.45%
EcoR1 Capital, LLC
2,228,000US$5.2m0%0.23%
5.79%
Logos Global Management, L.P.
2,000,000US$4.7m0%0.29%
5.66%
Frazier Life Sciences Management, LP
1,953,467US$4.6m0%0.11%
3.58%
Millennium Management LLC
1,235,827US$2.9m0%no data
3.17%
Balyasny Asset Management L.P.
1,096,179US$2.6m10,400%no data
2.56%
The Vanguard Group, Inc.
883,149US$2.1m222%no data
2.14%
Sio Capital Management, LLC
740,000US$1.7m0%0.29%
1.79%
Ikarian Capital, LLC
617,327US$1.4m0%0.24%
1.69%
Columbia Management Investment Advisers, LLC
584,368US$1.4m21.2%no data
1.58%
Patrick Crutcher
546,606US$1.3m0%no data
1.32%
Two Sigma Investments, LP
456,333US$1.1m0%no data
1.17%
ADAR1 Capital Management, LLC
405,531US$944.9k1,400%0.07%
1.02%
Renaissance Technologies LLC
353,339US$823.3k0%no data
0.8%
Monashee Investment Management, LLC
274,862US$640.4k0%0.37%
0.74%
Boothbay Fund Management, LLC
254,412US$592.8k43.9%0.01%
0.71%
AstralBio, Inc.
246,087US$573.4k0%no data
0.7%
Hudson Bay Capital Management LP
242,076US$564.0k0%no data
0.65%
Noesis Capital Management Corp
224,200US$522.4k0%0.07%
0.64%
Geode Capital Management, LLC
222,610US$518.7k47.1%no data
0.57%
Walleye Capital LLC
198,375US$462.2k0%no data
0.53%
Antonio Parada
183,823US$428.3k0%no data
0.46%
Jefferies Financial Group Inc.
160,000US$372.8k0%no data
0.37%
UBS Asset Management AG
126,556US$294.9k12,700,000%no data
0.35%
Marshall Wace LLP
121,286US$282.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/19 05:49
End of Day Share Price 2026/02/18 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

iBio, Inc. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian Kemp DolliverBrookline Capital Markets
Keay NakaeChardan Capital Markets, LLC
Douglas BuchananCitizens JMP Securities, LLC